
Share on:
MCRA acquired Vorpal Technologies, K.K., a leader in Japan in regulatory, reimbursement, clinical study management and importing/Designated Marketing Authorization Holder services.
Below is a brief overview of Vorpal’s track record:
- Vorpal’s team is made up of bi-lingual/bi-cultural experts with strong English-speaking skills and extensive experience in helping foreign companies navigate the Japanese market.
- In 2021, Vorpal secured 7 Class III and Class IV Shonin approvals (reportedly more than any other consulting firm this year).
- Vorpal secured 4 new category premium reimbursement listings and currently have 4 ongoing programs. To give some context about our activity and visibility in this field, Japan only issues between 10 and 20 new category reimbursement listings per year.
- Over its nine-year history, Vorpal has obtained 49 approvals, most of which are high risk-category, new and innovative medical devices.
The partnership will allow MCRA to offer clients a single partner for implementing a global commercialization strategy across the US, EU and Japan.
Source: MCRA
JAV
Julie A. Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
RELATED ARTICLES
Carpenter Technology’s Proposed Cobalt-free Alternative to CoCrMo Alloys for Articulating Orthopedic Implants
Oct 02 2025 , Carpenter Technology
Croom Medical Introduces Biofuse 3D-Printed Lattice Technology
Sep 16 2025 , Julie A. Vetalice
EXALTA is the New Brand Unifying Intech, Tyber and Resolve
Sep 10 2025 , Julie A. Vetalice